Naiane Lima Costa
Overview
Explore the profile of Naiane Lima Costa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bahia L, Mello K, Lemos L, Costa N, Mulinari E, Malerbi D
Diabetol Metab Syndr
. 2023 Nov;
15(1):242.
PMID: 38001509
Background: Hypoglycemia is a barrier to optimal glucose control in the treatment of both type 1 (T1DM) and type 2 diabetes mellitus (T2DM). Blood glucose monitoring is essential in diabetes...
2.
Drummond P, Dos Santos R, Silveira L, Malta J, Moreira Reis A, Costa N, et al.
Curr Drug Saf
. 2023 Aug;
19(3):356-367.
PMID: 37592770
Background: Survival in multiple myeloma (MM) has improved in the past years with the introduction of immunomodulators and proteasome inhibitors. However, chemotherapyinduced peripheral neuropathy (CIPN) is associated with both drug...
3.
Machado T, Menezes de Padua C, Drummond P, Silveira L, Malta J, Dos Santos R, et al.
J Geriatr Oncol
. 2022 Jan;
13(4):493-498.
PMID: 35086797
Objective: To investigate the use of fall risk-increasing drugs (FRIDs) and associated factors and to assess the use of medicines that induce neuropathy in older adults with multiple myeloma (MM)....
4.
Malta J, Drummond P, Silveira L, Costa N, Dos Santos R, Machado C, et al.
Curr Med Res Opin
. 2022 Jan;
38(8):1275-1283.
PMID: 35083943
Objective: Multiple myeloma (MM) is an incurable hematological cancer and its treatment is geared to promote better Health-Related Quality of Life (HRQoL). We aimed to assess HRQoL and compare scores...
5.
Silveira L, Menezes de Padua C, Drummond P, Malta J, Dos Santos R, Costa N, et al.
Front Pharmacol
. 2021 May;
12:651523.
PMID: 34045961
Validate the Treatment Adherence Measure (TAM) instrument in outpatients with MM concerning construct validity, reliability and the ceiling and floor effects. This cross-sectional study included patients diagnosed with MM previously...
6.
Malta J, Silveira L, Drummond P, Costa N, Dos Santos R, Reis I, et al.
Curr Med Res Opin
. 2021 May;
37(7):1163-1169.
PMID: 33979261
Purpose: Multiple myeloma (MM) is a rare but treatable hematological cancer, which makes the health-related quality of life (HRQoL) an important patient-report outcome measure in clinical studies. The Quality of...
7.
Silveira L, de Padua C, Drummond P, Malta J, Santos R, Costa N, et al.
J Oncol Pharm Pract
. 2021 Feb;
28(2):373-380.
PMID: 33583251
Purpose: The treatment of multiple myeloma (MM) has advanced with the introduction of immunomodulators (IMiDS). Thalidomide is the IMiD available in Brazil with free access to MM patients. Adherence to...